Virtually every medical therapy in use today owes its existence to animal experiments. But we can't assume what works in animals will in humans. And sometimes, the mismatch can be dangerous.
L’expertise universitaire, l’exigence journalistique
Articles sur Clinical trials
Affichage de 81 à 100 de 149 articles
Systematic reviews are rarely applied to basic research. A new study shows how they could separate good data from bad, saving millions in research dollars and speeding life-saving treatments.
In many trials, patients have been told they're getting the sugar pill. They still got better.
Rare diseases may only affect a handful of people but their treatment benefits everyone.
In many cases, the most appropriate treatment for a health condition isn't a drug. It could be a recommendation for a dietary change, a specific exercise, or even a phone app.
Claims that stem cell treatments can repair spinal injuries right now are overblown. But it's not for lack of trying, and the science is certainly progressing.
Better technology to diagnose, treat and manage the disease early enough is needed to improve the survival rates of childhood cancer in sub Saharan Africa.
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
Trials into the effectiveness of drugs and treatments struggle to recruit enough participants, yet we rely on their results anyway.
Pay-for-performance for doctors works brilliantly ... but only in theory.
Why didn’t you hear about a recent big study on a new heart medication? Because the drug didn’t work. But that doesn't mean the study wasn't a success – it was.
A new animal study has shown injections of antibodies might protect against HIV infection, albeit for only a limited time.
The dramatic improvements in survival for children with cancer depend on clinical trials, and these trials depend on parents understanding the possible risks and benefits involved.
Human guinea pigs? On the occasion of Rennes drama, an explanation of what the drug trials in France and how they are controlled.
Meta-analyses that combine many different studies are the gold standard for medical evidence. But they are only as good research they examine.
Tighter regulations of medicines and devices have prevented countless deaths and disabilities. But regulation can't always protect us from harm.
Scientists are developing various products that can provide contraception and protection from sexually transmitted infections and HIV at the same time.
A collaboration between research and industry has produced a promising new drug that could transform many childrens' lives. It's also a case study in innovation done right.
Africa's pharmaceutical industry has mushroomed in the last ten years. But its ability to keep pace with demand is being held back by a number of factors, including a shortage of specialists.
Les contributeurs les plus fréquents
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Director of the Oxford Empathy Programme, University of Oxford
-
Epidemiologist, Cochrane
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Professor of Immunology, RMIT University
-
Professor of Medicine, Monash University
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Senior Research Fellow, Bioethics, University of Sydney
-
Ian Haines est un·e ami·e de La Conversation
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Head, Cancer Research Program, Monash University
-
Senior Lecturer in Medical Ethics and Law, St George's, University of London
-
Researcher, L’Université d’Ottawa/University of Ottawa
-
Professsor of Public Health; Co-Director Consortium for Advanced Research Training in Africa; Panel Member, Private Healthcare Market Inquiry, University of the Witwatersrand
-
Assistant Professor of Law, Saint Louis University
-
Associate professor, UNSW
